FORTEO™
Brand Name: FORTEO™
Composition: Teriparatide Injection (600 mcg / 2.4 ml solution for injection in a pre-filled pen, recombinant DNA origin)
Product Description
Medical Info
FORTEO™ is a prescription biologic medication containing Teriparatide (600 mcg/2.4 ml), manufactured by Eli Lilly. Delivered via a specialized, single-patient pre-filled delivery pen, it is a recombinant human parathyroid hormone analog intended strictly for subcutaneous use. It functions as an anabolic agent that actively stimulates new bone formation rather than merely slowing bone breakdown. This targeted therapy is primarily prescribed to treat advanced osteoporosis in postmenopausal women and men who face an elevated risk of systemic fractures, helping to restore skeletal architecture, increase mineral bone density, and safely improve structural bone strength over time.
Storage & Safety
Precautions & Warnings
Reconstitute only with the prescribed quantity of clean drinking water. Shake well before each use. Complete the full course as prescribed. Discard any unused suspension after 7 days of reconstitution.
Storage
Store in a cool, dry place below 25°C. Protect from light and moisture. Refrigeration after reconstitution is preferred.
Status
Keep all medicines out of reach of children.
